SNGX Soligenix, Inc.

Soligenix Inc focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/13/2013
Outstanding shares:  40,103,760
Average volume:  538,849
Market cap:   $36,013,176
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    834223307
ISIN:        US8342233074
Valuation   (See tab for details)
PE ratio:   -2.62
PB ratio:   2.48
PS ratio:   41.42
Return on equity:   -88.93%
Net income %:   -1,539.82%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy